Web Results



Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.

For the Treatment of Postmenopausal Osteoporosis Women at High ...


Learn how Prolia® (denosumab) can help in the treatment of postmenopausal osteoporosis for women at high risk for fracture.

Denosumab (Prolia, Xgeva) | Cancer Research UK


Apr 23, 2015 ... Read about the cancer treatment drug denosumab, otherwise known as Prolia or Xgeva, including what it is, how it works and possible side ...

Prolia - Amgen


PROLIA safely and effectively. See full prescribing information for. PROLIA. Prolia ® (denosumab). Injection, for subcutaneous use. Initial U.S. Approval: 2010.

Denosumab (Subcutaneous Route) Description and Brand Names ...


Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis ...

XGEVA® vs Zoledronic Acid Study Design & Analysis | XGEVA® MOA


Denosumab is an NCCN category 1–recommended treatment option for patients whose breast or prostate cancer has metastasized to bone1 1,2 ,2. Integrated

XGEVA® (denosumab) Mechanism of Action | RANKL


Watch the XGEVA® (denosumab) mechanism of action video.

Denosumab - Cancer Information - Macmillan Cancer Support


Get information about the monoclonal antibody Denosumab, which may be used to treat secondary bone cancer.

Prolia (Denosumab Injection) Patient Information: Side Effects and ...


Pictures of Prolia (Denosumab Injection), drug imprint information, side effects for the patient.

Denosumab: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for denosumab. Includes indications, proper use, special instructions, precautions, and possible side effects.

More Info

Denosumab Injection: MedlinePlus Drug Information


Jul 15, 2015 ... Denosumab injection (Prolia) is used to treat osteoporosis (a condition in which the bones become thin and weak and break easily) in men and ...

Denosumab - National Cancer Institute


Nov 30, 2010 ... This page contains brief information about denosumab and a collection of links to more information about the use of this drug, research results, ...

About the Center for Drug Evaluation and Research > Denosumab ...


Nov 27, 2015 ... On September 16, 2011, the U.S. Food and Drug Administration granted approval for denosumab (Prolia, Amgen Inc.) as a treatment to ...